DE69005572T2 - Fusionsproteine und Herstellung davon. - Google Patents

Fusionsproteine und Herstellung davon.

Info

Publication number
DE69005572T2
DE69005572T2 DE90116878T DE69005572T DE69005572T2 DE 69005572 T2 DE69005572 T2 DE 69005572T2 DE 90116878 T DE90116878 T DE 90116878T DE 69005572 T DE69005572 T DE 69005572T DE 69005572 T2 DE69005572 T2 DE 69005572T2
Authority
DE
Germany
Prior art keywords
fused protein
protein
producing
heat
recombinant dna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE90116878T
Other languages
English (en)
Other versions
DE69005572D1 (de
Inventor
Yukio Fujisawa
Shuji Hinuma
Aki Mayumi
Tatsuo Yamamoto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Application granted granted Critical
Publication of DE69005572D1 publication Critical patent/DE69005572D1/de
Publication of DE69005572T2 publication Critical patent/DE69005572T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/55—Fusion polypeptide containing a fusion with a toxin, e.g. diphteria toxin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE90116878T 1989-09-08 1990-09-03 Fusionsproteine und Herstellung davon. Expired - Fee Related DE69005572T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP23372889 1989-09-08

Publications (2)

Publication Number Publication Date
DE69005572D1 DE69005572D1 (de) 1994-02-10
DE69005572T2 true DE69005572T2 (de) 1994-04-07

Family

ID=16959644

Family Applications (1)

Application Number Title Priority Date Filing Date
DE90116878T Expired - Fee Related DE69005572T2 (de) 1989-09-08 1990-09-03 Fusionsproteine und Herstellung davon.

Country Status (5)

Country Link
EP (1) EP0418626B1 (de)
JP (1) JPH03178995A (de)
AT (1) ATE99331T1 (de)
CA (1) CA2024918A1 (de)
DE (1) DE69005572T2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2050425A1 (en) * 1990-09-03 1992-03-04 Yoshiaki Uda Pharmaceutical composition and its mucous use
GB9316745D0 (en) * 1993-08-12 1993-09-29 Medeva Holdings Bv Vaccine compositions
US5681571A (en) * 1993-10-08 1997-10-28 Duotol Ab Immunological tolerance-inducing agent
CA2205130A1 (en) * 1994-11-17 1996-05-30 Jan Roland Holmgren Immunogens for stimulating mucosal immunity
JPH11510164A (ja) * 1995-07-26 1999-09-07 マキシム ファーマシューティカルズ ポリヌクレオチドの粘膜送達
CU22629A1 (es) * 1997-03-06 2000-12-22 Ct Ingenieria Genetica Biotech Formulaciones inmunopotenciadoras para uso vacunal
JP4623625B2 (ja) 2003-07-24 2011-02-02 株式会社ＡＭＢｉＳ ヘテロ型５量体組換えワクチン
CN100334212C (zh) * 2005-07-25 2007-08-29 华东理工大学 一种用于原核分泌、融合表达大肠杆菌热敏毒素b亚单位的载体

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL78775A (en) * 1985-05-15 1992-06-21 Biotech Australia Pty Ltd Oral vaccines
US5109113A (en) * 1986-05-02 1992-04-28 Genentech, Inc. Membrane anchor fusion polypeptides
US5112749A (en) * 1987-10-02 1992-05-12 Praxis Biologics, Inc. Vaccines for the malaria circumsporozoite protein
CA2004738A1 (en) * 1988-12-07 1990-06-07 University Of Leicester Heat-labile toxin b subunit fusion proteins

Also Published As

Publication number Publication date
EP0418626A2 (de) 1991-03-27
DE69005572D1 (de) 1994-02-10
EP0418626A3 (en) 1991-09-25
ATE99331T1 (de) 1994-01-15
EP0418626B1 (de) 1993-12-29
CA2024918A1 (en) 1991-03-09
JPH03178995A (ja) 1991-08-02

Similar Documents

Publication Publication Date Title
FI102768B1 (fi) Hybridi-DNA-molekyyli ja menetelmä fibronektiiniä sitovan proteiinin valmistamiseksi
DE68929115D1 (de) Verfahren zur Herstellung von menschlichem Serumalbumin in Hefe
DE3587422D1 (de) Fuer ein hirudinaehnliches protein kodierende dns-sequenz und verfahren zur herstellung eines solchen proteins.
SE8204810D0 (sv) Recombinant dna molecule, transformed microorganism and process for producing protein a
HUT65974A (en) Cloning of chicken anaemia dna
ATE68826T1 (de) Verfahren zur herstellung von reifem, menschlichem serum-albumin.
DE69005572T2 (de) Fusionsproteine und Herstellung davon.
EP0395706A4 (en) Production of gonorrheal pi proteins and vaccines
AU605155B2 (en) A structural phosphoprotein (PP 15) of human cytomegalovirus, and the preparation and use thereof
SE8105516L (sv) Syntetisk dna och forfarande for framstellning derav
PT97427A (pt) Processo para a preparacao de proteinas de fusao de tendamistato em estreptomicetas
DE69024392T2 (de) Verfahren zur Reinigungbvon Aussenmembran-Protein von Haemophilus influenzae
ZA874677B (en) Dna sequence,recombinant dna molecules and process for producing the newcastle disease virus fusion protein or equivalent polypeptides,obtained products and preparations containing same
SE8403929D0 (sv) Recombinant dna molecule, transformed microorganisms and process for producing penicillin v amidase
AU4866485A (en) Cyclic double-stranded dna, process for its preparation, microorganism containing said cyclic double-stranded dna, andprocess for preparing protein containing antigen determinant
LTIP1543A (en) Process for enzymatic decomposition of recombinant proteins by means of iga-protease, fused protein, recombinant dna, cell
FI934079A (fi) Menetelmä fuusioproteiinin valmistamiseksi
IE871743L (en) "dna sequence, recombinant dna molecules and process for¹producing the newcastle disease virus fusion protein or¹equivalent polypeptides, obtained products and preparations¹containing the same"
DK135686A (da) Polypeptid med en antigen determinant af herpes simplex-virus, dets fremstilling og anvendelse

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee